Previous close | 5.05 |
Open | 5.00 |
Bid | 5.00 x 100 |
Ask | 5.05 x 100 |
Day's range | 4.87 - 5.28 |
52-week range | 2.68 - 8.22 |
Volume | |
Avg. volume | 283,293 |
Market cap | 157.83M |
Beta (5Y monthly) | 4.04 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The average of price targets set by Wall Street analysts indicates a potential upside of 218.2% in Capricor (CAPR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The mean of analysts' price targets for Capricor (CAPR) points to a 229.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
As you might know, Capricor Therapeutics, Inc. ( NASDAQ:CAPR ) just kicked off its latest annual results with some very...